“Incidents in Pharma” can refer to a wide range of unplanned events or deviations that occur during pharmaceutical manufacturing, testing, storage, or distribution. These incidents can affect product quality, patient safety, regulatory compliance, and operational efficiency. Common Types of Incidents…
Change Control in pharma is a structured, documented process used to manage any planned change that may impact product quality, patient safety, regulatory compliance or validated status of facilities, utilities, equipment, documents and computerized systems. A robust change control system…
In pharma, artworks are the controlled master designs for all printed packaging components—cartons, labels, foils, leaflets, shippers, inserts, booklets, and sometimes on-pack overprint layouts. They translate the approved product information (name, strength, composition, warnings, storage, manufacturer details, batch/expiry fields, barcodes/2D…
Line clearance in the pharmaceutical industry is a critical process that ensures a production line is free from contaminants, previous product residues, and unauthorized materials before starting a new batch or product. It helps maintain Good Manufacturing Practices (GMP) and…
In pharma, market complaints are a critical part of the Pharmaceutical Quality System (PQS) because they can signal potential risks to patient safety, product quality defects, counterfeit infiltration, or distribution failures. What complaints typically include Common complaint categories are: How…
Corrective and Preventive Action (CAPA) in pharma is the structured system used to eliminate the cause of an existing problem (corrective action) and to prevent potential problems from occurring (preventive action). CAPA is a core element of the Pharmaceutical Quality…
In pharma, an incident is any unplanned event that disrupts normal operations or creates a potential or actual risk to product quality, patient safety, regulatory compliance, data integrity, environment, or worker safety. Incidents can occur in manufacturing, packaging, QC laboratories,…
In pharma, a deviation is any departure from an approved instruction, established procedure, validated process, specification, or expected condition during manufacturing, packaging, testing, storage, or distribution. Deviations matter because they can affect product quality, patient safety, data integrity, and regulatory…
Regulatory affairs (RA) in pharma is a critical function that ensures pharmaceutical products meet legal and safety standards before they reach the market. It involves compliance with national and international regulations governing drug development, approval, manufacturing, marketing, and post-market surveillance.…
Supply Chain Management (SCM) in pharma is the end-to-end control of materials, information, quality, and product flow from API/excipient suppliers to the patient—while maintaining GMP/GDP compliance, preventing counterfeits, and assuring continuous availability. The next layer is materials management and inventory…
You can access this page after paying the subscription fees of 21 ₹ /month only.